Community acquired bacteremia by Sphingomonas paucimobilis: Two rare case reports

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 12, 2013, Pages 2947-2949

  Nandy, Shyamasree ^a   Dudeja, Mridu ^a   Das, Ayan Kumar ^a   Tiwari, Rachna ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Primary bacteremia,Community acquired; Sphingomonas paucimobilis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; C REACTIVE PROTEIN; CARBAPENEM DERIVATIVE; CATALASE; CEFTRIAXONE; CHLORAMPHENICOL; ESCULIN; HEMOGLOBIN; OXIDOREDUCTASE; QUINOLONE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BILIRUBIN BLOOD LEVEL; BLOOD CULTURE; BLOOD SAMPLING; CASE REPORT; CHILD; CHILL; COMMUNITY ACQUIRED BACTEREMIA; ERYTHROCYTE COUNT; FEMALE; FEVER; GRAM NEGATIVE SEPSIS; GRAM STAINING; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PRESCHOOL CHILD; RIGOR; SPHINGOMONAS PAUCIMOBILIS; THROMBOCYTE COUNT; VOMITING;

EID: 84891050197     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/6459.3802     Document Type: Article

References (9)

1. Holmes B, Owen RJ, Evans A, Malnick H, Wilcox WR. Pseudomonas paucimobilis, a new species isolated from human clinical specimens, the hospital environment, and other sources. Int J Syst Bacteriol. 1977; 27:133-46.
2. Yabuuchi E, Yano I, Oyaizu H, Hashimoto Y, Ezaki T, Yammoto H. Proposals of Sphingomonas paucimobilis gen. nov. and comb. nov. Sphingomonas parapaucimobilis sp. nov., Sphingomonas yanoikuyaesp. nov., Sphingomonas adhaesiva sp. nov., Sphingomonas capsulata comb. nov., and two genospecies of the genus Sphingomonas. Microbiol Immunol. 1990;34:99-119.
3. Lin JN, Lai CH, Chen YH, Lin HL, Huang CK, Chen WF, et al. Sphingomonas paucimobilis bacteremia in humans: 16 case reports and a literature review. J Microbiol Immunol Infect. 2010; 43: 35-42.
4. Krishna S, Ciraj AM, Bairy I, Shobha KL. Sphingomonas paucimobilis urinary tract infection in a renal transplant recipient: a rare case. Int J of Med and Pub Health. 2011 Vol. 1 No. 1 pp. 47-49.
5. Toh HS, Tay HT, Kuar WK, Weng TC, Tang HJ, Tan CK. Risk factors associated with Sphingomonas paucimobilis infection. J Microbiol Immunol Infect. 2011;44:289-95.
6. Kucukbayrak A, Demirli K, Ozdemir D, Kucukbayrak ZS, & Hakyemez IN. Primary Bacteremia Associated With Sphingomonas paucimobilis During the Late Period in a Patient With Ventriculoperitoneal Shunt After Neurosurgery With Literature Review. Neurosurgery Quarterly. 2012; 22(1), 38-40.
7. Bayram N, Devrim I, Apa H, Gülfidan G, Türkyi{dotless}lmaz HN, & Günay I. Sphingomonas paucimobilis Infections in Children: 24 Case Reports. Mediterranean Journal of Hematology and Infectious Diseases. 2013 Vol 5(1).
8. Cheong HS, Wi YM, Moon SY, Kang CI, Son JS, Ko KS et al. Clinical features and treatment outcomes of infections caused by Sphingomonas paucimobilis. Infect Control Hosp Epidemiol. 2008;29(10):990-2.
9. Al-Anazi KA, Abu Jafar S, Al-Jasser AM, Al-Shangeeti A, Chaudri NA, Al Jurf, MD & Al-Mohareb FI. Septic shock caused by Sphingomonas paucimobilis bacteremia in a patient with hematopoietic stem cell transplantation. Transpl Infect Dis. 2008; vol 10, pp 142-44.